Convatec Group (LSE:CTEC) Total Equity: £1,134 Mil (As of Dec. 2025)


LSE:CTEC Convatec Group PLC LSE:CTEC
77 GF Score
Price £2.14
GF Value £2.55
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Convatec Group Total Equity?

Convatec Group LSE:CTEC +1.04% 77 Total Equity is £1,134 Mil as of Dec. 2025. GuruFocus rates LSE:CTEC with a GF Score™ of 77/100 and a GF Value™ of £2.55 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Convatec Group's total equity for the quarter that ended in Dec. 2025 was £1,134 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Convatec Group Total Equity Historical Data

* Premium members only.

The historical data trend for Convatec Group's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Convatec Group Total Equity Chart

Convatec Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,274.49 1,321.56 1,337.23 1,336.00 1,133.95

Convatec Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,337.23 1,300.75 1,336.00 1,334.85 1,133.95
LSE:CTEC
77GF Score
Convatec Group PLC LSE:CTEC
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Convatec Group Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Convatec Group's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2824.407-1690.461
=1,134

Convatec Group's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2824.407-1690.461
=1,134

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of £1,134 Mil mean?
Convatec Group (LSE:CTEC) has a Total Equity of £1,134 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Convatec Group and its competitors.
Is Convatec Group's Total Equity too high?
Convatec Group's current Total Equity is £1,134 Mil. Overall, Convatec Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Total Equity compare to ISRG and BDX?
Convatec Group's Total Equity of £1,134 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Convatec Group and its competitors. Convatec Group's current Total Equity is £1,134 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (LSE:CTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.55, compared to a current price of £2.14 — trading 16.2% below its estimated fair value. The current Total Equity is £1,134 Mil. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Convatec Group (LSE:CTEC), the current Total Equity is £1,134 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Convatec Group (LSE:CTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of £2.14 is trading 16.2% below its estimated GF Value™ of £2.55. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for LSE:CTEC:

  • Total Equity: £1,134 Mil
  • GF Value™: £2.55 vs. price of £2.14 (16.2% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the LSE:CTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for LSE:CTEC

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.14
Price
£2.55
GF Value